Latest Earnings Results: Q3 '26
Estimated EPS
$2.33
Reported EPS
$2.67
Surprise
+14.66%
Estimated Rev
$77M
Reported Rev
$78.75M
Surprise
+2.26%
• Reported GAAP EPS of $2.67 down -13.59% YoY • Reported revenue of $78.75M down -9.37% YoY • Ligand raised 2026 adjusted earnings per diluted share guidance to approximately $9.50 to $9.75 from approximately $9.00 to $9.50, and reaffirmed total revenue guidance of $270M to $310M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $2.88 | -- | -- | N/A |
Q3 '26 | $2.33 | $2.67 | 14.66% | BEAT |
Q2 '26 | $1.95 | $2.37 | 21.48% | BEAT |
Q1 '26 | $1.82 | $1.63 | -10.23% | MISSED |
Q4 '25 | $1.50 | $2.02 | 34.92% | BEAT |